ArticleCancer immunology research2022

Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid Tumors.

Pradip Bajgain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.